Related Experiment Video

Updated: Feb 4, 2026

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

11.0K

Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy

Jinfang Zhang1, Fabin Dang1, Junming Ren2

  • 1Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA; These authors contributed equally to this work.

Trends in Biochemical Sciences
|October 6, 2018
PubMed

Insights

Programmed death-ligand 1 (PD-L1) helps cancers evade immune attack. Understanding PD-L1 regulation is key to improving cancer immunotherapy response rates for more patients.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Programmed death-ligand 1 (PD-L1) is expressed in human cancers, interacting with PD-1 on immune cells to promote immune evasion.
  • Antibodies targeting the PD-1/PD-L1 pathway can restore anti-tumor immunity by reactivating cytotoxic T cells.
  • Many cancer patients do not respond to PD-1/PD-L1 blockade, indicating a need to understand resistance mechanisms.

Purpose of the Study:

  • To review the molecular mechanisms regulating PD-L1 expression in cancer.
  • To explore the role of PD-L1 in modulating the anti-tumor immune response.
  • To identify strategies for optimizing PD-1/PD-L1 blockade therapies.

Main Methods:

  • Literature review of studies on PD-L1 expression and regulation.
  • Analysis of the interplay between PD-L1 and anti-tumor immunity.
  • Synthesis of findings to inform therapeutic strategies.

Main Results:

  • PD-L1 expression levels on tumor cells correlate with clinical response to PD-1/PD-L1 therapies.
  • Understanding PD-L1 regulation is crucial for predicting and enhancing treatment efficacy.
  • Various molecular pathways control PD-L1 expression, offering potential therapeutic targets.

Conclusions:

  • Optimizing PD-1/PD-L1 blockade requires a deeper understanding of PD-L1 regulation.
  • Targeting PD-L1 expression mechanisms may improve response rates in a broader patient population.
  • Further research into PD-L1's role in the tumor immune microenvironment is essential.
Keywords:
Cancer immunotherapyPD-1/PD-L1checkpoint blockadecombination therapiestumor-infiltrating lymphocyte

More Related Videos

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

1.2K
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.2K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
PD Controller: Design01:26

PD Controller: Design

In automotive engineering, car suspension systems often employ Proportional Derivative (PD) controllers to enhance performance. PD controllers are utilized to adjust the damping force in response to road conditions. A controller, acting as an amplifier with a constant gain, demonstrates proportional control, with output directly mirroring input.
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
658
Time-Domain Interpretation of PD Control01:07

Time-Domain Interpretation of PD Control

Proportional-Derivative (PD) control is a widely used control method in various engineering systems to enhance stability and performance. In a system with only proportional control, common issues include high maximum overshoot and oscillation, observed in both the error signal and its rate of change. This behavior can be divided into three distinct phases: initial overshoot, subsequent undershoot, and gradual stabilization.
Consider the example of control of motor torque. Initially, a positive...
408
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.8K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.9K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.8K